goralatide has been researched along with Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barateau, V; Bignon, J; Blanc-Brude, O; Duriez, M; Ebrahimian, TG; Le Ricousse-Roussanne, S; Lévy, BI; Liu, JM; Markovits, D; Mees, B; Silvestre, JS; Tobelem, G; Vilar, J; Waeckel, L; Wdzieczak-Bakala, J | 1 |
1 other study(ies) available for goralatide and Ischemia
Article | Year |
---|---|
Tetrapeptide AcSDKP induces postischemic neovascularization through monocyte chemoattractant protein-1 signaling.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cell Line, Transformed; Chemokine CCL2; Endothelium, Vascular; Femoral Artery; Hindlimb; Ischemia; Mice; Mice, Inbred C57BL; Monocytes; Neovascularization, Physiologic; Oligopeptides; Signal Transduction | 2006 |